AKT1 and cancer: We can estimate that OSC inhibition by Ro 48-8071 in tumor vasculature and cancer cells may reduce OHC levels and, consequently, inhibit Hh and PI3-kinase/Akt pathways, thus impairing tumour angiogenesis and metastasis formation.